| P2093 | author name string | Björn Fischler | |
| | Thomas H Casswall | |
| P2860 | cites work | Intravenous immunoglobulin G in the treatment of patients with chronic glomerulonephritis: clinical experience lasting 15 years | Q77699302 |
| | Efficacy and safety of immunization for pre- and post- liver transplant children | Q78294024 |
| | Use of licensed vaccines for active immunization of the immunocompromised host | Q24533456 |
| | Vaccinations for Adult Solid-Organ Transplant Recipients: Current Recommendations and Protocols | Q27477631 |
| | Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancy | Q28168298 |
| | Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections | Q28189095 |
| | Immunisation of patients with systemic lupus erythematosus: the current state of play | Q33731281 |
| | Nutrition and immunology: from the clinic to cellular biology and back again | Q33798940 |
| | Immunogenicity of pneumococcal conjugate vaccines | Q33900055 |
| | Herd immunity and herd effect: new insights and definitions | Q33925309 |
| | Immunization of pediatric solid organ transplant candidates and recipients | Q33942411 |
| | Influenza infection in patients before and after liver transplantation | Q34026783 |
| | Immunologic correlates of protection induced by vaccination | Q34140244 |
| | Vaccination against infectious disease following hematopoietic stem cell transplantation | Q34219146 |
| | Vaccination and systemic lupus erythematosus: the bidirectional dilemmas | Q34227160 |
| | Immunisations in solid-organ transplant recipients | Q34579905 |
| | Micronutrient malnutrition, infection, and immunity: an overview | Q34660263 |
| | Immunization in rheumatic diseases of childhood: an audit of the clinical practice of British Paediatric Rheumatology Group members and a review of the evidence | Q34770242 |
| | Immunology of vaccination. | Q34784857 |
| | Safety and immunogenicity of influenza vaccination in individuals infected with HIV. | Q35023501 |
| | On natural and artificial vaccinations | Q35034062 |
| | HAV infection in chronic liver disease: a rationale for vaccination | Q35126718 |
| | Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life | Q35172905 |
| | Glucocorticoid resistance in inflammatory bowel disease | Q35216179 |
| | Hepatitis B vaccination and multiple sclerosis: evidence from a systematic review | Q35216915 |
| | Natural history and risk factors in fulminant hepatic failure | Q35544950 |
| | Hepatitis B vaccination in children with juvenile idiopathic arthritis. | Q35554552 |
| | The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy | Q35596353 |
| | Prevention of life-threatening infections due to encapsulated bacteria in children with hyposplenia or asplenia: a brief review of current recommendations for practical purposes | Q35604607 |
| | Current therapy of ulcerative colitis in children | Q35609674 |
| | Immunization of children after solid organ transplantation | Q35622750 |
| | T helper cells and efficacy of Haemophilus influenzae type b conjugate vaccination. | Q35628223 |
| | Pharmacology of calcineurin antagonists | Q35710811 |
| | Review article: hepatitis vaccination in patients with chronic liver disease | Q35714136 |
| | Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children | Q35853410 |
| | A review of the varicella vaccine in immunocompromised individuals | Q35869409 |
| | Guidelines for immunizations in patients with inflammatory bowel disease | Q35912322 |
| | Immunization in children with chronic renal failure: a practical approach | Q35926987 |
| | Viral prophylaxis in organ transplant patients | Q35962532 |
| | Meta-analysis: the effect of age on immunological response to hepatitis B vaccine in end-stage renal disease | Q35966083 |
| | Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine | Q35987793 |
| | Targeting the molecular target of rapamycin (mTOR). | Q35997230 |
| | Liver transplantation and hepatitis C virus: systematic review of antiviral therapy. | Q36034079 |
| | Routine immunizations in adult renal transplant recipients | Q39090245 |
| | Use of Oseltamivir to control influenza complications after bone marrow transplantation | Q39199981 |
| | Immunogenicity of a two-dose regime of varicella vaccine in children with cancers. | Q40536886 |
| | Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). | Q40549077 |
| | Influenza virus infection in adult solid organ transplant recipients | Q40579386 |
| | Inflammatory bowel disease in children and adolescents in Sweden, 1984-1995. | Q41728353 |
| | Influenza and parainfluenza respiratory viral infection requiring admission in adult lung transplant recipients | Q43628676 |
| | The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation | Q43890868 |
| | Immunization in children with chronic renal failure | Q43913811 |
| | The immune development in a child born to a cyclosporin A-treated woman with systemic lupus erythematosus/polymyositis | Q44114234 |
| | Effect of prednisone on response to influenza virus vaccine in asthmatic children | Q44116833 |
| | Disseminated BCG-osteomyelitis in congenital immunodeficiency | Q44264233 |
| | Impact of nutritional status on antibody responses to different vaccines in undernourished Gambian children. | Q44413572 |
| | Limited contribution of humoral immunity to the clearance of measles viremia in rhesus monkeys. | Q44716186 |
| | Influenza vaccination among heart transplant recipients | Q44880353 |
| | Hepatitis B vaccine response before and after transplantation in 55 extrahepatic biliary atresia children | Q45169985 |
| | Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation | Q45735386 |
| | Immunogenicity of inactivated hepatitis A vaccine in children with chronic liver disease | Q47349877 |
| | Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens. | Q50760701 |
| | Influenza vaccination following liver transplantation in children. | Q50927965 |
| | Severe influenza infection in a chronic hepatitis C carrier: failure of protective serum HI antibodies after IM vaccination. | Q51638761 |
| | Influenza vaccination in heart transplant recipients. | Q54721560 |
| | Varicella vaccination in children with chronic renal failure | Q57954179 |
| | Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy | Q60211000 |
| | Vaccine recommendations for patients on chronic dialysis. The Advisory Committee on Immunization Practices and the American Academy of Pediatrics | Q64130640 |
| | Measles vaccination after orthotopic liver transplantation | Q72803985 |
| | Rheumatic disorders developed after hepatitis B vaccination | Q73115081 |
| | Immunogenicity of pneumococcal vaccine in heart transplant recipients | Q73424174 |
| | Immunity to diphtheria and tetanus in a young population on a dialysis regimen or with a renal transplant | Q73457505 |
| | Response to diphtheria and tetanus booster vaccination in pediatric renal transplant recipients | Q73585302 |
| | Characterization of the impaired antipneumococcal polysacharide antibody production in immunosuppressed pediatric patients following cardiac transplantation | Q73803222 |
| | Immunogenicity and safety of a virosomal influenza vaccine in HIV-infected children | Q74289720 |
| | Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation | Q77658512 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | drug discovery | Q1418791 |
| P304 | page(s) | 725-738 | |
| P577 | publication date | 2005-10-01 | |
| P1433 | published in | Expert Review of Vaccines | Q15756339 |
| P1476 | title | Vaccination of the immunocompromised child | |
| P478 | volume | 4 | |